The dose that got you here and the dose that keeps you here
What the labels permit, what clinicians do, and the size of the gap between them.
Shortage listings
Page 12 of 13 of this archive, newest first.
A shortage listing ends. 19 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 10 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The 22-day notice: how a compounding wind-down works in Norway
The document is four pages. Three of them are about dates.
The lowest effective dose is a real concept with almost no data behind it
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced one — has not been randomised.
The 23-day notice: how a compounding wind-down works in Canada
The document is four pages. Three of them are about dates.
A shortage listing ends. 11 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 19 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 19 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 21 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The 23-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
The 14-day notice: how a compounding wind-down works in Denmark
The document is four pages. Three of them are about dates.
Why people actually stop, in the order they actually stop
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
The 28-day notice: how a compounding wind-down works in Brazil
The document is four pages. Three of them are about dates.
A shortage listing ends. 24 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 17 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
What SURMOUNT-1 tells us about maintenance, and what it does not
A survey of the maintenance evidence, which is shorter than the survey of the withdrawal evidence.
The 28-day notice: how a compounding wind-down works in Canada
The document is four pages. Three of them are about dates.
What happens when the drug is taken away: three randomised answers
The regain trajectories, arm by arm, with the estimands named.
The dose that got you here and the dose that keeps you here
What the labels permit, what clinicians do, and the size of the gap between them.